Sign Up Today and Learn More About Ratio Therapeutics Stock
Invest in or calculate the value of your shares in Ratio Therapeutics or other pre-IPO companies through EquityZen's platform.
Ratio Therapeutics Stock (RATT)
Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
About Ratio Therapeutics Stock
Founded
2021
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ratio Therapeutics Press Mentions
Stay in the know about the latest news on Ratio Therapeutics
Ratio Therapeutics Announces the Appointment of Former Senator William Cowan to its Board of Directors
prnewswire • Aug 05, 2024
Ratio Therapeutics welcomes Mo Cowan to its Board of Directors
talent4boards • Jun 26, 2024
Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals
prnewswire • Jun 04, 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
biospace • Jun 04, 2024
Ratio Therapeutics Appoints Marc Becker as Chief Financial Officer and Chief Operating Officer
citybiz • Jun 04, 2024
Ratio Therapeutics Management
Leadership team at Ratio Therapeutics
Chief Data Officer
Jacob Hesterman
CFO
Reed Malleck
Join now and verify your accreditation status to gain access to:
- Ratio Therapeutics current valuation
- Ratio Therapeutics stock price
- Available deals in Ratio Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Ratio Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Ratio Therapeutics through EquityZen funds. These investments are made available by existing Ratio Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ratio Therapeutics stock?
Shareholders can sell their Ratio Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
